Stockreport

Immunovant Reports Financial Results for the Quarter Ended December 31, 2024 [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF 11 min read In This Article IMVT Immunovant Inc. Lead asset IMVT-1402 rapidly progressing with now six Investigational New Drug (IND) applications cleared and p [Read more]